Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
Allergan Botox Settlement and Corporate Integrity Agreement
This week, the United States Department of Justice (DOJ) announced that it has reached a resolution regarding the previously…
Milwaukee Journal Sentinel: The Case of BMP-2 Ignoring Any Benefit from…
Progress in medicine is essential for discovering new ways to make people healthier, experience less pain, and to live longer. The…
Price Regulation and the Consequences to Innovation
A recent white paper published by the European School of Management and Technology (ESMT), carried out “An Economic Assessment of…
Pharmacists Expanded Role in Improving Patient Outcomes
In addition to outlining patient’s medications, and teaching them what times of day to take the drugs that will help control…
DOJ Targets Pharmaceutical Manufacturers In Foreign Corrupt Practices Act…
According to a recent articles in the Financial Times and New York Times, the US Department of Justice (DOJ) and the Securities…
Senator Al Franken Calls on Additional Incentives for Medical Device…
Recently, Senator Al Franken (D-MN) called on Congress to create extra incentives for medical device makers to tackle rare…
FDA: Warning Letters May Double in 2010
A recent article in MM&M highlighted how warning letters (found here) sent by the Food and Drug Administration’s (FDA)…
Decrease in Commercial Support of CME Correlates with Increase in…
While the percentage of commercial support for continuing medical education (CME) has continued to drastically drop over the past…
Pharmaceutical Marketing Lawsuits Slowing Considerably
According to the Rx Compliance Report, “federal prosecutors are reporting that the pace of new qui tam filings (whistle blower…
IFPMA Joint Industry Position on the Publication of Clinical Trial Results…
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is the global non-profit NGO…